BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

934 related articles for article (PubMed ID: 30378107)

  • 1. Surgical portosystemic shunts versus transjugular intrahepatic portosystemic shunt for variceal haemorrhage in people with cirrhosis.
    Brand M; Prodehl L; Ede CJ
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD001023. PubMed ID: 30378107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Portosystemic shunts versus endoscopic intervention with or without medical treatment for prevention of rebleeding in people with cirrhosis.
    Simonetti RG; Perricone G; Robbins HL; Battula NR; Weickert MO; Sutton R; Khan S
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD000553. PubMed ID: 33089892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical portosystemic shunts versus devascularisation procedures for prevention of variceal rebleeding in people with hepatosplenic schistosomiasis.
    Ede CJ; Nikolova D; Brand M
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD011717. PubMed ID: 30073663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary prevention of variceal bleeding in adults with previous oesophageal variceal bleeding due to decompensated liver cirrhosis: a network meta-analysis.
    Plaz Torres MC; Best LM; Freeman SC; Roberts D; Cooper NJ; Sutton AJ; Roccarina D; Benmassaoud A; Iogna Prat L; Williams NR; Csenar M; Fritche D; Begum T; Arunan S; Tapp M; Milne EJ; Pavlov CS; Davidson BR; Tsochatzis E; Gurusamy KS
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013122. PubMed ID: 33784794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanded polytetrafluoroethylene (ePTFE)-covered stents versus bare stents for transjugular intrahepatic portosystemic shunt in people with liver cirrhosis.
    Zhu P; Dong S; Sun P; Belgaumkar AP; Sun Y; Cheng X; Zheng Q; Li T
    Cochrane Database Syst Rev; 2023 Aug; 8(8):CD012358. PubMed ID: 37531575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Portosystemic shunts versus endoscopic therapy for variceal rebleeding in patients with cirrhosis.
    Khan S; Tudur Smith C; Williamson P; Sutton R
    Cochrane Database Syst Rev; 2006 Oct; 2006(4):CD000553. PubMed ID: 17054131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment for bleeding oesophageal varices in people with decompensated liver cirrhosis: a network meta-analysis.
    Roberts D; Best LM; Freeman SC; Sutton AJ; Cooper NJ; Arunan S; Begum T; Williams NR; Walshaw D; Milne EJ; Tapp M; Csenar M; Pavlov CS; Davidson BR; Tsochatzis E; Gurusamy KS
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013155. PubMed ID: 33837526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transjugular intrahepatic portosystemic shunts for adults with hepatorenal syndrome.
    Gonzalez-Garay AG; Serralde-Zúñiga AE; Velasco Hidalgo L; Flores García NC; Aguirre-Salgado MI
    Cochrane Database Syst Rev; 2024 Jan; 1(1):CD011039. PubMed ID: 38235907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic injection of cyanoacrylate glue versus other endoscopic procedures for acute bleeding gastric varices in people with portal hypertension.
    Ríos Castellanos E; Seron P; Gisbert JP; Bonfill Cosp X
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD010180. PubMed ID: 25966446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparision between portosystemic shunts and endoscopic therapy for prevention of variceal re-bleeding: a systematic review and meta-analysis.
    Zhou GP; Sun LY; Wei L; Qu W; Zeng ZG; Liu Y; Jiang YZ; Zhu ZJ
    Chin Med J (Engl); 2019 May; 132(9):1087-1099. PubMed ID: 30913064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage.
    Jalan R; Elton RA; Redhead DN; Finlayson ND; Hayes PC
    J Hepatol; 1995 Aug; 23(2):123-8. PubMed ID: 7499782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Band ligation versus no intervention for primary prevention of upper gastrointestinal bleeding in adults with cirrhosis and oesophageal varices.
    Vadera S; Yong CWK; Gluud LL; Morgan MY
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD012673. PubMed ID: 31220333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Band ligation versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis.
    Cifuentes LI; Gattini D; Torres-Robles R; Gana JC
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD011561. PubMed ID: 33522602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early TIPS versus endoscopic therapy for secondary prophylaxis after management of acute esophageal variceal bleeding in cirrhotic patients: a meta-analysis of randomized controlled trials.
    Halabi SA; Sawas T; Sadat B; Jandali A; Halabi HA; Halabi FA; Kapoor B; Carey WD
    J Gastroenterol Hepatol; 2016 Sep; 31(9):1519-26. PubMed ID: 26858143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sclerotherapy versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis.
    Gattini D; Cifuentes LI; Torres-Robles R; Gana JC
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD011573. PubMed ID: 32133620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage.
    Sahagun G; Benner KG; Saxon R; Barton RE; Rabkin J; Keller FS; Rosch J
    Am J Gastroenterol; 1997 Sep; 92(9):1444-52. PubMed ID: 9317060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early transjugular intrahepatic portosystemic shunt for acute variceal bleeding: a systematic review and meta-analysis.
    Zhou GP; Jiang YZ; Sun LY; Zhu ZJ
    Eur Radiol; 2021 Jul; 31(7):5390-5399. PubMed ID: 33409783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transjugular intrahepatic portosystemic shunts and portal hypertension-related complications.
    Siramolpiwat S
    World J Gastroenterol; 2014 Dec; 20(45):16996-7010. PubMed ID: 25493012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transjugular intrahepatic portosystemic shunt prevents rebleeding in cirrhotic patients having cavernous transformation of the portal vein without improving their survival.
    Li LN; Sun XY; Wang GC; Tian XG; Zhang MY; Jiang KT; Zhang CQ
    J Dig Dis; 2019 Feb; 20(2):89-96. PubMed ID: 30629804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distal splenorenal shunt versus transjugular intrahepatic portal systematic shunt for variceal bleeding: a randomized trial.
    Henderson JM; Boyer TD; Kutner MH; Galloway JR; Rikkers LF; Jeffers LJ; Abu-Elmagd K; Connor J;
    Gastroenterology; 2006 May; 130(6):1643-51. PubMed ID: 16697728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.